Please select the eligibility criteria that correspond to the clinical trial below.
Title: Yoga And Cardiovascular Health Trial
Brief Summary: The benefits of alternative therapeutic approaches, such as yoga, are poorly understood and this is particularly true of the beneficial effects on cardiovascular disease (CVD) risk. It is hoped that a better understanding of the value of this therapy will provide a sound scientific basis for including yoga in mainstream clinical practice. The investigators propose to study a group of 80 participants (40 Indian Asians and 40 Europeans) recruited from a cardiac rehabilitation programme in West London post-angioplasty as treatment for an acute coronary syndrome. Those who agree will undergo a series of baseline and follow-up measurements. 20 Indian Asians and 20 Europeans will be randomized to the yoga intervention plus their standard cardiac rehabilitation programme (usual care), and the remaining 20 Indian Asians and 20 Europeans will be randomized to usual care alone. Baseline and follow-up measurements will be performed on all participants. In order to determine the acute effects of yoga the group randomised to the yoga intervention will also undergo a series of acute tests before and after their first yoga session.


Options:
A: Inclusion Criteria (patients): Men and women who

* are having first-time non-emergency CABG surgery
* are judged ready for discharge
* are being discharged to home \[either their own or to family/friends\]
* have access to and are able to communicate over a telephone
* are able to read, write and understand English

Inclusion Criteria (peers): Men and women who

* have undergone CABG surgery within the last 5 years
* have access to and are able to communicate clearly over a telephone
* are able to read, write and understand English
* have attended a formal cardiac rehabilitation program
* are not associated with the current in-hospital peer volunteer program
B: Inclusion Criteria:

(i) men and women with CVD (ischemic heart disease, atrial fibrillation, heart failure and patients with implantable cardioverter-defibrillator); (ii) at least 18 years of age; (iii) own, or have regular access to, either a smartphone (Android or iOS operating system), tablet or laptop/desktop computer; and (iv) able to understand English.

Exclusion Criteria:

(i) patients with planned surgical intervention (will be approached after surgery); (ii) another household member in the study; and (iii) unable to provide informed consent.
C: Inclusion Criteria:

* Aged 35-80 years.
* Male or female.
* European or Indian Asian descent.
* Able to understand English or Punjabi.
* Referred to a cardiac rehabilitation programme in West London post-angioplasty as treatment for an acute coronary syndrome.

Exclusion Criteria:

* Adults under 35 years or above 80 years.
* Adults aged 35-80 years who are not competent to give consent.
* Co-morbid disease or mobility limitations that would preclude participation in cardiac rehabilitation and our investigations.
D: Inclusion Criteria:

* Patients admitted to hospitals throughout New Jersey or at the University of Pennsylvania Health System who are discharged (or scheduled to be discharged) to their homes with a principal or secondary diagnosis code of International Classification of Diseases, 9th Revision, Clinical Modification (ICD-9-CM) 410 (except when the fifth digit was 2)
* a length of stay of 1 to 180 days
* Aged 18 to 80 years
* Be discharged to home
* Prescribed at least 2 of these 4 medication categories (statin, aspirin, beta-blocker, anti-platelet)

Exclusion Criteria:

* cannot give consent
* have a markedly shortened life expectancy (diagnosis of metastatic cancer, end-stage renal disease on dialysis, or dementia)

Answer: C